Changes in programmed death-ligand 1 expression during cisplatin treatment in patients with head and neck squamous cell carcinoma

Programmed death-ligand 1 (PD-L1) expression is regarded as a predictive marker for anti-PD-1/PD-L1 therapy. The purpose of study was to explore the changes in PD-L1 expression in head and neck squamous cell carcinoma (HNSCC) during treatment. Paired HNSCC tissues prior to and after cisplatin-based...

Descripción completa

Detalles Bibliográficos
Autores principales: Ock, Chan-Young, Kim, Sehui, Keam, Bhumsuk, Kim, Soyeon, Ahn, Yong-Oon, Chung, Eun-Jae, Kim, Jin-Ho, Kim, Tae Min, Kwon, Seong Keun, Jeon, Yoon Kyung, Jung, Kyeong Chun, Kim, Dong-Wan, Wu, Hong-Gyun, Sung, Myung-Whun, Heo, Dae Seog
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Impact Journals LLC 2017
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5716702/
https://www.ncbi.nlm.nih.gov/pubmed/29228662
http://dx.doi.org/10.18632/oncotarget.18542

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5716702/
https://www.ncbi.nlm.nih.gov/pubmed/29228662
http://dx.doi.org/10.18632/oncotarget.18542

Ejemplares similares